Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Ophthalmology
Published September 29, 2026
Cholesteryl Ester Transfer Protein Inhibition and Risk of Age-Related Macular Degeneration.
September 30, 2026
Medspoke
Medspoke
European Journal of Cancer
Published September 24, 2026
00:00
--:--
Reflections on adjuvant pembrolizumab for triple-negative breast cancer treated with the KEYNOTE-...
September 30, 2026
Share
Reflections on adjuvant pembrolizumab for triple-negative breast cancer treated with the KEYNOTE-522 regimen: Is it really necessary?
https://www.medspoke.co/channel_journal?id=795&tap_id=14710
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
The Breast
Published September 25, 2026
Analysis of outcomes of nab-paclitaxel compared to other taxanes in early breast cancer: A study ...
September 30, 2026
Why are you reporting this TALK?
